Health Cloud

Search documents
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce?
ZACKSยท 2025-07-24 16:21
Core Insights - Veeva Systems (VEEV) is transitioning away from Salesforce's infrastructure, aiming for full independence by September 2025, which will enhance control over product development and innovation in the life sciences sector [1][6] - The Vault platform is central to Veeva's growth, with positive client feedback indicating smoother integration and improved performance [2][6] - Veeva is investing in R&D and customer support to facilitate the transition, which may impact short-term margins but is expected to drive long-term differentiation [2][6] Industry Context - The end of the partnership with Salesforce reflects a broader industry trend towards purpose-built platforms, with Salesforce continuing to expand its healthcare offerings [3] - IQVIA remains a significant competitor in the life sciences technology space, leveraging its data assets and service offerings, although its technology is less integrated than Veeva's [4] Financial Performance - Veeva's shares have increased by 36% year-to-date, outperforming the industry growth of 8.2% [5] - The forward price-to-sales ratio for Veeva is 14.3, above the industry average, indicating a premium valuation [8] - The Zacks Consensus Estimate for Veeva's fiscal 2026 earnings suggests a 15.8% increase compared to the previous year [10]